Ghassan K. Abou-Alfa, et al. ASCO Annual Meeting 2016, June 3-7, 2016, Chicago Illinois Download the poster here Poster Presentation
Year: 2016
Transgene Announces Poster Presentation at ASCO Annual Meeting on the Phase 3 PHOCUS Clinical Trial with Pexa-Vec Oncolytic Immunotherapy
20160531 – ASCO_Poster_PR_V2_clean
Composition of the Board of Directors and Statutory Auditors
20160525 – nomination Mr Beret – us
Next Annual General Meeting on 24 May 2016
documents
Transgene Reports First Quarter 2016 Business Update
20160421 PR VEN Q1 2016 – V4 clean
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allow their intratumoral delivery and an improved tumor-growth inhibition
Jean Baptiste Marchand, et al. AACR Annual Meeting 2016, April 16-20, 2016, E.N. MorialConvention Center, New Orleans, Louisiana Download the poster here Poster Presentation
Transgene Presents Pre-Clinical Data at AACR on a New Generation Oncolytic Viral Immunotherapy Armed with an Anti-PD1 Monoclonal Antibody (poster)
20160419 AACR Poster PR Final
9th Kempen & Co Healthcare & Life Sciences Conference – Amsterdam
Transgene Hires Two Senior Pharmaceutical Industry Executives to Join Leadership Team
20160317 Appointments PR Final
Transgene Reports 2015 Financial Results and Provides Outlook for 2016 (webcast)
20160309 FY 2015 results version FINALE
